Healthpeak Properties (DOC) AI Stock Analysis

• Market Cap: $12.78B
• Dividend Yield: 6.05%
• Average Volume (3M): 7.79M
• Price to Earnings (P/E): 76.7
• Beta (1Y): 0.61
• Revenue Growth: 15.91%
• EPS Growth: -49.49%
• Country: US
• Employees: 387
• Sector: Real Estate
• Sector Strength: 52
• Industry: REIT - Healthcare Facilities
• EPS (TTM): 0.05
• Shares Outstanding: 694,923,460
• 10 Day Avg. Volume: 6,193,006
• 30 Day Avg. Volume: 7,793,253
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.72
• Enterprise Value/Revenue: 7.88
• Enterprise Value/Gross Profit: 13.04
• Enterprise Value/Ebitda: 13.80
• 1Y Price Target: $20.21
• Price Target Upside: 9.90% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 13

• Rating: 65 Neutral
• Price Target: $18.50 ▲(0.60% Upside)

Healthpeak Properties shows a solid financial foundation with strong cash flow and revenue growth, but faces challenges in profitability margins and technical indicators suggest bearish trends. The high P/E ratio indicates potential overvaluation, though the dividend yield is appealing. Earnings call insights reveal strong performance in key segments, but challenges in the lab segment and life sciences sector pose risks.

Positive Factors

Earnings

2Q25 Adj-FFO was in line with the Street, with solid portfolio SSNOI (+3.5%), boosted by MOBs/CCRCs.

Market Confidence

The company repurchased $94 million in shares year-to-date, signaling confidence in its own stock value.

Partnerships

DOC announced a new partnership with Hines, indicating potential growth and collaboration opportunities.

Negative Factors

Growth Projections

DOC's original lab SSNOI guidance (+3-4%) appears optimistic with a modest acceleration implied for 2H25 from the 2Q run rate.

Market Outlook

DOC expects a deceleration in the Life Science occupancy.

Occupancy Challenges

Occupancy results were a disappointment for both, resulting from users of space facing continued headwinds from capital raising and lingering impacts from regulatory concerns, namely around the NIH and the FDA.

Healthpeak Properties Business Overview & Revenue Model

Company Description

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

How the Company Makes Money

Healthpeak Properties generates revenue primarily through rental income from its diverse portfolio of healthcare-related properties. The company leases its properties to various healthcare operators and service providers, benefiting from long-term leases that often include rent escalations over time. Key revenue streams include senior housing operations, where Healthpeak collects rental payments from residents; life science facilities, where tenants are typically biotech and pharmaceutical companies; and medical office buildings leased to healthcare providers. Additionally, Healthpeak may engage in property development and redevelopment projects, which can enhance its asset value and yield further income. Significant partnerships with leading healthcare operators and institutions also contribute to the company's stable revenue base and growth potential.

Healthpeak Properties Financial Statement Overview

Summary

Healthpeak Properties exhibits a solid financial position with strong revenue growth and efficient cash flow generation, despite some pressure on profitability margins. The balance sheet reveals moderate leverage, which is manageable but requires monitoring. Overall, the company is well-positioned in its industry, though attention to profitability improvement would benefit future performance.

Income Statement

Healthpeak Properties has shown consistent revenue growth with a TTM (Trailing-Twelve-Months) increase of 3.53% over the previous year, indicating a positive growth trajectory. Gross profit margin stands at 60.4%, showcasing strong operational efficiency. However, the net profit margin has decreased to 5.9% in the TTM, highlighting reduced profitability. The EBIT margin is at a healthy 18%, but the decline in net income suggests some margin pressure.

Balance Sheet

The company's debt-to-equity ratio is 1.18, indicating moderate leverage, which is typical in the REIT industry. The return on equity is relatively low at 2.1% in the TTM, reflecting limited profitability on equity. The equity ratio of 40% indicates a balanced capital structure, but the reliance on debt could pose potential risks in changing interest rate environments.

Cash Flow

Free cash flow has shown a robust growth of 16.26% in the TTM, demonstrating strong cash generation capabilities. The operating cash flow to net income ratio is high at 7.5, indicating efficient cash conversion. The company maintains a solid free cash flow to net income ratio, supporting its ability to cover dividends and reinvest in growth.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.80B	2.70B	2.18B	2.06B	1.90B	1.64B
Gross Profit	1.69B	1.63B	1.28B	1.20B	1.12B	862.33M
EBITDA	1.60B	1.61B	1.27B	1.39B	970.63M	1.13B
Net Income	164.92M	243.14M	306.01M	500.45M	505.54M	413.56M
Balance Sheet
Total Assets	19.81B	19.94B	15.70B	5.10B	5.18B	4.41B
Cash, Cash Equivalents and Short-Term Investments	163.28M	119.82M	138.99M	126.83M	158.29M	44.23M
Total Debt	9.35B	9.02B	7.08B	6.71B	6.37B	6.48B
Total Liabilities	11.22B	10.88B	8.77B	2.10B	2.19B	1.67B
Stockholders Equity	7.93B	8.40B	6.35B	6.65B	6.52B	6.73B
Cash Flow
Free Cash Flow	1.24B	1.07B	956.24M	218.53M	214.99M	199.41M
Operating Cash Flow	1.24B	1.07B	956.24M	258.40M	247.56M	233.30M
Investing Cash Flow	-644.52M	-113.80M	-576.75M	-38.47M	-603.22M	-1.01B
Financing Cash Flow	-596.14M	-941.42M	-337.30M	-222.07M	363.03M	246.45M

Healthpeak Properties Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 18.39
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DOC, the sentiment is Positive. The current price of 18.39 is above the 20-day moving average (MA) of 17.46, above the 50-day MA of 17.61, and below the 200-day MA of 18.51, indicating a neutral trend. The MACD of 0.19 indicates Negative momentum. The RSI at 65.79 is Neutral, neither overbought nor oversold. The STOCH value of 85.04 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DOC.

Healthpeak Properties Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NHI	79 Outperform	$3.67B	24.66	10.49%	4.59%	6.87%	7.23%
OHI	76 Outperform	$12.61B	26.66	10.47%	6.21%	12.73%	23.51%
SBRA	74 Outperform	$4.56B	25.03	6.66%	6.31%	6.89%	240.70%
DOC	65 Neutral	$12.78B	76.69	1.97%	6.05%	15.91%	-49.49%
Sector *	63 Neutral	$7.09B	13.59	-0.50%	6.85%	4.08%	-25.24%
HR	61 Neutral	$6.15B	―	-7.59%	6.48%	-7.16%	23.40%
MPW	49 Neutral	$2.67B	―	-25.97%	6.94%	27.66%	18.03%

Healthpeak Properties Corporate Events

Healthpeak Properties Completes $500 Million Senior Notes Offering

On August 14, 2025, Healthpeak OP, LLC, a subsidiary of Healthpeak Properties, completed a $500 million offering of 4.750% senior notes due 2033. The net proceeds, estimated at $491.4 million, are intended for repaying borrowings and general corporate purposes, potentially impacting the company’s financial flexibility and strategic initiatives.

Healthpeak Properties Announces $500M Senior Notes Offering

On August 5, 2025, Healthpeak Properties, Inc. announced that its operating company, Healthpeak OP, LLC, entered into an underwriting agreement for a public offering of $500 million in senior unsecured notes due 2033. The net proceeds, estimated at approximately $491.4 million, will be used to repay borrowings under its commercial paper program and for general corporate purposes, including potential acquisitions and capital expenditures. The offering is expected to close on August 14, 2025, and involves several underwriters, with the notes being fully guaranteed by Healthpeak and its affiliates.

Healthpeak Properties Updates Tax Considerations in SEC Filing

On February 5, 2025, Healthpeak Properties filed a Post-Effective Amendment to a Registration Statement with the SEC, updating the discussion on U.S. federal income tax considerations related to its REIT status and securities offerings. This amendment replaces previous tax considerations and highlights the complexities and potential changes in tax laws affecting REIT qualifications and operations, which could impact Healthpeak’s tax obligations and investor returns.

Healthpeak Properties Reports Q2 2025 Financial Results

Healthpeak Properties reported its second quarter 2025 financial results, showing a net income of $0.05 per share and a 3.5% growth in Total Merger-Combined Same-Store Cash NOI. The company executed significant lease agreements and entered into new development agreements to support outpatient expansion, while also achieving sustainability milestones and earning prestigious industry awards.